Follow
Paul Brennan
Title
Cited by
Cited by
Year
Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F
P Brennan, JW Babbage, BMT Burgering, B Groner, K Reif, DA Cantrell
Immunity 7 (5), 679-689, 1997
5251997
Proteomics analysis of bladder cancer exosomes
JL Welton, S Khanna, PJ Giles, P Brennan, IA Brewis, J Staffurth, ...
Molecular & Cellular Proteomics 9 (6), 1324-1338, 2010
4512010
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
C Pepper, TT Lin, G Pratt, S Hewamana, P Brennan, L Hiller, R Hills, ...
Blood 112 (9), 3807-3817, 2008
3012008
Effects of oxidants and antioxidants on nuclear factor B activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals
P Brennan, LAJ O'Neill
Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression 1260 (2 …, 1995
2741995
Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+ CD25+ regulatory T cells versus CD8+ memory T cells
MA Burchill, CA Goetz, M Prlic, JJ O’Neil, IR Harmon, SJ Bensinger, ...
The Journal of Immunology 171 (11), 5853-5864, 2003
2582003
The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
S Hewamana, S Alghazal, TT Lin, M Clement, C Jenkins, ML Guzman, ...
Blood 111 (9), 4681-4689, 2008
2262008
The NF-kappaB subunit, Rel A, is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukaemia and represents a promising therapeutic target
S Hewamana, TT Lin, M Clement, S Alghazal, C Fagan, C Rowntree, ...
BRITISH JOURNAL OF HAEMATOLOGY 141, 118-119, 2008
2262008
Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site
M Saitoh, N Pullen, P Brennan, D Cantrell, PB Dennis, G Thomas
Journal of Biological Chemistry 277 (22), 20104-20112, 2002
2252002
Proteomics technologies for the global identification and quantification of proteins
IA Brewis, P Brennan
Adv Protein Chem Struct Biol 80, 1-44, 2010
2162010
p70s6k integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytes
P Brennan, JW Babbage, G Thomas, D Cantrell
Molecular and cellular biology 19 (7), 4729-4738, 1999
1811999
Inhibition of Nuclear Factor [kappa] B by Direct Modification in Whole Cells--Mechanism of Action of Nordihydroguaiaritic Acid, Curcumin and Thiol Modifiers
P Brennan, LAJ O'Neill
Biochemical pharmacology 55 (7), 965-973, 1998
1711998
2-mercaptoethanol restores the ability of nuclear factor kappa B (NF kappa B) to bind DNA in nuclear extracts from interleukin 1-treated cells incubated with pyrollidine …
P Brennan, LA O'Neill
Biochemical Journal 320 (Pt 3), 975, 1996
1611996
CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells
T Vaisitti, S Aydin, D Rossi, F Cottino, L Bergui, G D'Arena, L Bonello, ...
Leukemia 24 (5), 958-969, 2010
1302010
Epstein-Barr virus LMP1 blocks p16INK4a–RB pathway by promoting nuclear export of E2F4/5
N Ohtani, P Brennan, S Gaubatz, E Sanij, P Hertzog, E Wolvetang, ...
The Journal of cell biology 162 (2), 173-183, 2003
1292003
Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering
AC Raby, E Le Bouder, C Colmont, J Davies, P Richards, B Coles, ...
The Journal of Immunology 183 (1), 506-517, 2009
1222009
Reactive oxygen species and mitochondrial sensitivity to oxidative stress determine induction of cancer cell death by p21
I Masgras, S Carrera, PJ de Verdier, P Brennan, A Majid, W Makhtar, ...
Journal of Biological Chemistry, 2012
1182012
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabine
E Walsby, G Pratt, H Shao, AY Abbas, PM Fischer, TD Bradshaw, ...
Oncotarget 5 (2), 375, 2014
922014
Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD
CL Watkins, P Brennan, C Fegan, K Takayama, I Nakase, S Futaki, ...
Journal of Controlled Release 140 (3), 237-244, 2009
902009
Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways
CA Fielding, K Sandvej, A Mehl, P Brennan, M Jones, M Rowe
Journal of virology 75 (19), 9129-9141, 2001
882001
LY294002 and rapamycin co‐operate to inhibit T‐cell proliferation
EM Breslin, PC White, AM Shore, M Clement, P Brennan
British journal of pharmacology 144 (6), 791-800, 2005
862005
The system can't perform the operation now. Try again later.
Articles 1–20